-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
phase iii
-
A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of CFS, Strayer et al, 2012
Background Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a severely debilitating disease of unknown pathogenesis consisting of a variety of symptoms including severe fatigue. The objective of the study was to examine the efficacy and safety of a TLR-3 agonist, rintatolimod...- cassava7
- Thread
- ampligen phase iii randomized controlled trial rct rintatolimod
- Replies: 15
- Forum: ME/CFS research